Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 12
  • Journal CiteScore: 8.06
  • Journal Impact Factor: 1.0
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
Share This Page

Mini Review - (2022) Volume 13, Issue 8

Orthopaedic Research in United States during the Covid-19 Era

William Stetson*
Department of Orthopaedic Surgery, University of Miami, USA
*Correspondence: William Stetson, Department of Orthopaedic Surgery, University of Miami, USA, Email:

Received: 01-Aug-2022, Manuscript No. Iptb- 22- 13045; Editor assigned: 05-Aug-2022, Pre QC No. Iptb- 22- 13045; Reviewed: 19-Aug-2022, QC No. Iptb- 22- 13045; Revised: 23-Aug-2022, Manuscript No. Iptb- 22- 13045 (R); Published: 31-Aug-2022, DOI: 10.21767/ 2172-0479.100250


The quick and broad use of telemedicine across disciplines, including orthopaedics, was prompted by the coronavirus pandemic. In a short amount of time, newly approved telehealth practises have gone from being an experiment to the standard as a result of a series of circumstances, starting with payers, moving on to providers adoption, and then reciprocated by patients. The COVID-19 era is not the end of telemedicine, according to orthopaedic surgeons, but there are still a lot of long-term adjustments that payers, providers, and patients need to make if tele health is to continue. The purpose of this study is to describe the chain of events that led to the widespread adoption of telemedicine in orthopaedic clinics around the world, to show how irreversible its adoption is, and to spark discussion about next measures that may be taken to maintain its advantages.


Translational stroke; Discovery biology; Molecular therapy


The COVID-19 coronavirus pandemic has brought to light the vulnerability of individuals, groups, and economies alike, allowing cross-sectional leadership to consider the numerous factors beyond of our control as well as the few factors that are. Since face-to-face interaction was once thought to be necessary for communications and transactions, the very nature of this infection altered daily operations. As a result, it has compelled markets and systems to change in ways that strike a compromise between public health stewardship and just "getting the job done [1]." The inherent vulnerability of the patient as a result of health being a largely inelastic demand and the influence of third-party insurers governing the reimbursement framework distinguish healthcare from typical economic goods or services [2]. As a result, medical providers are held to a different and higher standard [3]. When providing services to its clients, under industry standards. Because of this and other factors, HIPAA was put into place to safeguard patient information and privacy rights at a time when insurance companies generally controlled what services providers could bill for. The U.S. Department of Health and Human Treatments did, however, expand the indications for telehealth in the course of COVID-19 to allow physicians to offer more services, and insurers followed suit by paying for those services. The growing body of research shows that both patients and clinicians have embraced this temporary telehealth framework and greatly profited from its features [4]. 1 Following this paradigm shift, orthopaedic practises have begun to offer telemedicine services, citing the COVID-19 epidemic as their inspiration. 1 However, it is still to be seen whether payers, including CMS and commercial insurers, would acknowledge however, it is unclear whether payers, including CMS and private insurers, will acknowledge the benefits of telehealth in the post-COVID-19 future, as they did during the epidemic [5]. It remains to be seen if the other parties involved in this discussion specifically, the healthcare systems, practise types, and providers and patients—have adopted telemedicine as a temporary solution or as a means of long-term survival. In this essay, we hope to spark discussion about whether newly developed care models from the COVID-19-induced telehealth era will last into the post-pandemic period. Our team has compiled some of the research on telemedicine in orthopaedics currently available and connected it to the findings of our Global Orthopaedic Trauma Survey that details the impact of COVID-19 on international practises. The fundamental purpose of telehealth is to increase patient access to care. It was developed as a result of the realisation that technology might be used to enhance patient access to healthcare through crucial services including virtual meetings, remote electronic consultations, and wireless communications [6]. Although there is little information available regarding the extent of telehealth's acceptance globally, market outlooks show continuous increase, largely as a result of the cumulative rise of emerging economies [7]. 3 Over the past ten years, the proportion of hospitals in the United States adopting some type of telehealth programme increased from 35% to 75%. However, the adoption of telehealth has been hindered by uneven coverage, excessive complexity, and consistently shifting rules on the part of the three biggest payers, commercial insurance, Medicare, and Medicaid.


Many people are reluctant to include telehealth. Furthermore, it hasn't been widely used in orthopaedics, particularly the orthopaedic trauma specialisation [8]. The regulations governing the gathering, using, and disclosing of sensitive patient data are known as "fair information practise principles" and are widely acknowledged. The HIPAA legislation in the US are made to uphold these ideals. However, HIPAA's safeguards and the potential legal repercussions of a violation have prevented both patients and clinicians from adopting telemedicine. Despite legal and insurance restrictions, telemedicine has shown to be economical. 5 It might offer a piecemeal solution to the spiralling healthcare costs that have become known in the US as an unaffordable burden. A number of clinical settings, including fields, have demonstrated improved treatment outcomes and quality of care as a result of the use of telemedicine. The study was open to 400 orthopaedic trauma specialists from 14 Latin American nations [9]. The eligibility requirements were having five or more years of experience as an orthopaedic surgeon, being a current member of the country's local orthopaedic association, and reporting spending more than 90% of one's working hours in skeletal trauma surgery [10]. The countries that were specifically targeted for the survey were Venezuela, Argentina, Brazil, Chile, Colombia, El Salvador, Ecuador, Guatemala, Honduras, Mexico, Panama, Paraguay, and Ecuador. Orthopaedic patients have reported high levels of telehealth satisfaction, especially when they are far away from the provider [11]. This backs up the idea that telemedicine might be employed to reduce disparities in patients' access to healthcare who live in remote areas. Interestingly, fewer patients After 60 days of declared lockdown throughout the entire region, we undertook a cross-sectional study to see how the COVID19 pandemic affected the orthopaedic trauma doctors in Latin America. An electronic questionnaire was created with the goal of gaining an understanding of the general COVID-19 situation in each nation as well as the financial and social effects it had on participants [12]. Questions centred on potential economic, psychological, and professional issues brought on by the illness [13]. Before being validated and translated into the official languages of the countries of Latin America, the questionnaire was reviewed by some researchers from the Clinical Decision Rules Study Group to look for inconsistencies or a lack of pertinent information [14]. The questionnaire was constructed in accordance with the recommendations made by Shaughnessy et al. employing 6 steps to produce reliable and valid results. We would like to thank the authors for their research, "Imbalanced development of anterior and posterior thorax is a causal factor causing scoliosis," which we read with great interest. The writers of this paper discussed a notion regarding the cause of idiopathic scoliosis, a subject that has attracted a lot of attention over time.


Due to the comparatively longer thoracic vertebra and shorter sternum, patients with scoliosis were shown to have a lower thoracic anteroposterior length ratio. In addition, quadrupedal mice that have had their sternal growth plates surgically removed develop scoliosis, while bipedal mice even develop scoliosis with a more pronounced curvature. Mice lacking the fibroblast growth factor receptor frequently develop scoliosis. Because it allows surgeons from around Latin America to participate, an online survey was used. Two researchers carried out a pilot test, and no adjustments were made. It took 10 to 15 minutes to complete the survey. Respondents were contacted by platform email with a brief letter outlining the project. In order to avoid being directly or indirectly recognised, participants might opt out of having their computers' IP addresses recorded. Only one response was permitted per browser or email address since the Multiple Responses option was disabled. It is possible that telehealth might be used to break down barriers in underdeveloped areas where opportunity costs associated with travel and time away from work are high [15]. Certain historical occurrences have radically altered how people, systems, and enterprises function. Changed the way society views the trade-off between privacy and security, transforming aviation security policies. Through instilling a dread of leaving their homes among the Chinese, the SARS pandemic dramatically increased consumer acceptance of online retail in ways never before seen in the world. 16 Similar to this, the COVID-19 pandemic has compelled healthcare professionals to virtually treat their patients in order to prevent viral transmission. Only until governance changed its perspective on the cost-benefit of data upon value optimization did telehealth immediately explode, and resources have already been allocated to promoting best practises and preventing fraud. Those who were on the front lines during COVID-19, like those surveyed for this study2, witnessed a clinical care mechanism that greatly benefited their patients and practises. Numerous contributions to the literature on how to use telehealth in orthopaedics most effectively have been made since the start of the pandemic. Orthopaedists now need to understand the potential benefits of telehealth for their patients, including the reduction of access inequities, avoidance of congested waiting rooms, time away from the office, improved patient satisfaction, and cost savings. To identify whether telehealth approaches produce favourable patient outcomes and where potential constraints may exist, more research is required.



Conflict of Interest



  1. Bornbusch A, Bates J (2013) Multiplicity in public health supply systems: a learning agenda. Glob Health Sci Pract 1: 154-159.
  2. Indexed at, Crossref, Google Scholar

  3. Simbar M, Ahmadi M, Ahmadi G, Alavi Majd HR (2006) Quality assessment of family planning services in urban health centres of Shahid Beheshti Medical Science University. Int J Health Care Qual Assur 19: 430-442.
  4. Indexed at, Crossref, Google Scholar

  5. Napoli A, Jagoda A (2007) Clinical policies: Their history, future, medical legal implications, and growing importance to physicians. J Emerg Med 33: 425-432.
  6. Indexed at, Crossref, Google Scholar

  7. Chen L, Chuang L, Chang C, Wang C, Wang I, et al. (2013) Evaluating self-management behaviors of diabetic patients in a telehealthcare program: longitudinal study over 18 months. J Med Internet Res 15: e266.
  8. Indexed at, Crossref, Google Scholar

  9. Sunyaev A, Dehling T, Taylor PL (2015) Availability and quality of mobile health APP privacy policies. J Am Med Inform Assoc 22: e28-e33.
  10. Indexed at, Crossref, Google Scholar

  11. Caulfield BM, Donnelly SC (2013) What is connected health and why will it change your practice? QJM 106: 703-707.
  12. Indexed at, Crossref, Google Scholar

  13. Skrøvseth SO, Årsand E, Godtliebsen F, Joakimsen RM (2015) Data-driven personalized feedback to patients with type 1 diabetes: a randomized trial. Diabetes Technol Ther 17: 482-489.
  14. Indexed at, Crossref, Google Scholar

  15. Oreffo R, Triffitt JT (1999) Future potentials for using osteogenic stem cells and biomaterials in orthopaedics. Bone 25: S5-S9.
  16. Indexed at, Crossref, Google Scholar

  17. Simon MJK, Regan WD (2021) COVID-19 pandemic effects on orthopaedic surgeons in British Columbia. J Orthop Surg Res 16: 161.
  18. Indexed at, Crossref, Google Scholar

  19. Fleischman AN, Rothman RH (2017) Important lessons learned from nearly a half-century of orthopaedic practice. Arch Bone Jt Surg 5: 206-207.
  20. Indexed at, Google Scholar

  21. Rao SS, Loeb AE, Amin RM (2020) Establishing telemedicine in an academic total joint arthroplasty practice: Needs and opportunities highlighted by the COVID-19 pandemic. Arthroplast.
  22. Indexed at, Crossref, Google Scholar

  23. Gopalkrishnan N (2018) Cultural diversity and mental health: Considerations for policy and practice. Public Health Front 6: 179.
  24. Indexed at, Crossref, Google Scholar

  25. Chisholm D (2005) Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization. World Psychiatry 4: 37-44.
  26. Indexed at, Google Scholar

  27. Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB, et al. (2014) Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes 12: 176.
  28. Indexed at, Crossref, Google Scholar

  29. Xu T, Pujara S, Sutton S, Rhee M (2018) Telemedicine in the management of type 1 diabetes. Prev Chronic Dis 15: E13.
  30. Indexed at, Crossref, Google Scholar

Citation: William Stetson (2022) Orthopaedic Research in United States during the Covid-19 Era. Transl Biomed, Vol. 13 No. 8: 248.